Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I–Mutant Fibroblasts

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Pharmacology

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.114.097204PMID 25788480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(ADP-Ribose) Polymerase

  2017cited by this paper
• NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease

  2014cited by this paper
• Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle.

  2014cited by this paper
• PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice

  2014cited by this paper
• Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3

  2014cited by this paper
• Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.

  2013cited by this paper
• NAD biosynthesis in humans--enzymes, metabolites and therapeutic aspects.

  2013cited by this paper
• Insight into Molecular and Functional Properties of NMNAT3 Reveals New Hints of NAD Homeostasis within Human Mitochondria

  2013cited by this paper
• Nicotinamide riboside, a trace nutrient in foods, is a Vitamin B3 with effects on energy metabolism and neuroprotection

  2013cited by this paper
• The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.

  2012cited by this paper
• Exploring the therapeutic space around NAD+

  2012cited by this paper
• The evolving role of mitochondria in metabolism Transcriptional integration of mitochondrial biogenesis

  2012cited by this paper
• The NAD metabolome — a key determinant of cancer cell biology

  2012cited by this paper
• On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

  2012cited by this paper
• PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.

  2011cited by this paper
• Pharmacological Effects of Exogenous NAD on Mitochondrial Bioenergetics, DNA Repair, and Apoptosis

  2011cited by this paper
• PARP-2 regulates SIRT1 expression and whole-body energy expenditure.

  2011cited by this paper
• NAD+ as a signaling molecule modulating metabolism.

  2011cited by this paper
• Poly(ADP‐Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

  2011cited by this paper
• Poly(ADP-ribose) Polymerase-1 Is a Nuclear Epigenetic Regulator of Mitochondrial DNA Repair and Transcription

  2011cited by this paper
• PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway.

  2010cited by this paper
• A critical approach to the therapy of mitochondrial respiratory chain and oxidative phosphorylation diseases.

  2009cited by this paper
• Global Analysis of Transcriptional Regulation by Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase in MCF-7 Human Breast Cancer Cells*♦

  2009cited by this paper
• Poly(ADP-ribose) Polymerase 1 Interacts with Nuclear Respiratory Factor 1 (NRF-1) and Plays a Role in NRF-1 Transcriptional Regulation*

  2009cited by this paper
• Emerging Roles of NAD+ and Its Metabolites in Cell Signaling

  2009cited by this paper
• Disorders from perturbations of nuclear‐mitochondrial intergenomic cross‐talk

  2009cited by this paper
• Mitochondrial disorders in the nervous system.

  2008cited by this paper
• Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration

  2008cited by this paper
• NAD+ and Vitamin B3: From Metabolism to Therapies

  2008cited by this paper
• Reciprocal Binding of PARP-1 and Histone H1 at Promoters Specifies Transcriptional Outcomes

  2008cited by this paper
• Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

  2007cited by this paper
• Mitochondrial Diseases: Therapeutic Approaches

  2007cited by this paper
• Molecular genetic and clinical aspects of mitochondrial disorders in childhood.

  2007cited by this paper
• Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I*

  2006influential reference
• Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans.

  2004influential reference
• Clinical and molecular findings in children with complex I deficiency.

  2004cited by this paper
• Minimum birth prevalence of mitochondrial respiratory chain disorders in children.

  2003cited by this paper
• Transcriptional Repression by Binding of Poly(ADP-ribose) Polymerase to Promoter Sequences*

  2002cited by this paper
• Mitochondrial diseases in man and mouse.

  1999cited by this paper
• A high rate (20%-30%) of parental consanguinity in cytochrome-oxidase deficiency.

  1998cited by this paper
• Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.

  1993cited by this paper

• Targeting Poly (ADP‐Ribose) Polymerase‐1 for the Treatment of Neurodegenerative Diseases

  2025cites this paper
• Complex I deficiency in m.3243A>G fibroblasts is alleviated by reducing NADH accumulation

  2023cites this paper
• NAD+ supplementation reverses the oxidative stress induced PARP1 signalling in D. discoideum

  2022cites this paper
• SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure

  2021cites this paper
• Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity

  2021cites this paper
• Resistance training increases muscle NAD+ and NADH concentrations as well as NAMPT protein levels and global sirtuin activity in middle-aged, overweight, untrained individuals

  2020cites this paper
• Mechanisms underlying neonate-specific metabolic effects of volatile anesthetics

  2020cites this paper
• NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

  2020cites this paper
• Diagnosis and Management of Mitochondrial Disorders

  2019influential citation
• Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies

  2019cites this paper
• Nutritional Regulation of Mitochondrial Function

  2019cites this paper
• Advances in the treatment of mitochondrial epilepsies.

  2019cites this paper
• Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin‐resistant men

  2019cites this paper
• PARP inhibition in platinum‐based chemotherapy: Chemopotentiation and neuroprotection

  2018cites this paper
• Metabolic pathways at the crossroads of diabetes and inborn errors

  2018cites this paper
• Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

  2018cites this paper
• Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders.

  2018cites this paper
• Chemotherapy-Induced Gastrointestinal Dysfunction and Enteric Neuropathy

  2017cites this paper
• Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity

  2017cites this paper
• The NAD+ precursor nicotinic acid improves genomic integrity in human peripheral blood mononuclear cells after X-irradiation.

  2017cites this paper
• Synthesis of β-Nicotinamide Riboside Using an Efficient Two-Step Methodology.

  2017cites this paper
• Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule

  2017cites this paper
• Chronic mTOR Inhibition by Rapamycin and Diabetes

  2016cites this paper
• Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease

  2016cites this paper
• Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3.

  2016cites this paper
• Sirtuin activation as a therapeutic approach against inborn errors of metabolism

  2016cites this paper
• NAD+ Supplementation Attenuates Methylmercury Dopaminergic and Mitochondrial Toxicity in Caenorhabditis Elegans.

  2016cites this paper
• NICOTINAMIDE RIBOSIDE DELIVERY GENERATES NAD+ RESERVES TO PROTECT VASCULAR CELLS AGAINST OXIDATIVE DAMAGE

  2015cites this paper
• Mitochondrial dysfunction in cardiac aging.

  2015cites this paper
• Leigh Syndrome

  2015cites this paper